LON:CVSG CVS Group (CVSG) Share Price, News & Analysis GBX 1,181 -16.00 (-1.34%) As of 03:59 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About CVS Group Stock (LON:CVSG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CVS Group alerts:Sign Up Key Stats Today's Range 1,175▼ 1,19450-Day Range 1,114▼ 1,29452-Week Range 1,062▼ 1,648Volume32,050 shsAverage Volume858,493 shsMarket Capitalization£828.55 millionP/E Ratio17.14Dividend Yield0.74%Price TargetGBX 1,724Consensus RatingModerate Buy Company Overview CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses. Read More CVS Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreCVSG MarketRank™: CVS Group scored higher than 63% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingModerate Buy Consensus RatingCVS Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 4 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialCVS Group has a consensus price target of GBX 1,724, representing about 44.0% upside from its current price of GBX 1,197.Amount of Analyst CoverageCVS Group has only been the subject of 1 research reports in the past 90 days.Read more about CVS Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of CVS Group is 17.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.60.Price to Earnings Ratio vs. SectorThe P/E ratio of CVS Group is 17.37, which means that it is trading at a less expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 77.20.Price to Earnings Growth RatioCVS Group has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCVS Group has a P/B Ratio of 3.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CVSG. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldCVS Group has a dividend yield of 0.74%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCVS Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of CVS Group is 12.34%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about CVS Group's dividend. News and Social Media3.2 / 5News Sentiment1.04 News SentimentCVS Group has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for CVS Group this week, compared to 1 article on an average week. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, CVS Group insiders have not sold or bought any company stock.Percentage Held by Insiders1.42% of the stock of CVS Group is held by insiders.Percentage Held by Institutions48.54% of the stock of CVS Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CVS Group's insider trading history. Receive CVSG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVS Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CVSG Stock News HeadlinesConverium Capital Sends Letter to CVS Group Board Highlighting Company's Undervaluation and Urging £100 Million Share BuybackMay 13 at 3:18 AM | tmcnet.comActivist Converium pushes UK's CVS to improve performance, FT reportsMay 13 at 3:18 AM | msn.comSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500. | Brownstone Research (Ad)Converium Capital Sends Letter to CVS Group Board Highlighting Company’s Undervaluation and Urging £100 Million Share BuybackMay 13 at 2:10 AM | financialpost.comFCVS Group strengthens board with appointment of Laura Hagan as independent directorApril 21, 2026 | tipranks.comCVS Group updates total voting rights following share capital confirmationMarch 31, 2026 | tipranks.comCVS Group says CMA veterinary ruling manageable and trading on trackMarch 24, 2026 | tipranks.comBarclays starts CVS Group at “equal weight,” Australia deals miss capital hurdlesMarch 20, 2026 | za.investing.comSee More Headlines CVSG Stock Analysis - Frequently Asked Questions How have CVSG shares performed this year? CVS Group's stock was trading at GBX 1,284 at the beginning of the year. Since then, CVSG shares have decreased by 6.8% and is now trading at GBX 1,197. How were CVS Group's earnings last quarter? CVS Group plc (LON:CVSG) released its quarterly earnings data on Thursday, February, 26th. The company reported $40.20 earnings per share for the quarter. CVS Group had a trailing twelve-month return on equity of 5.35% and a net margin of 2.31%. Read the conference call transcript. How do I buy shares of CVS Group? Shares of CVSG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of CVS Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Group investors own include Meta Platforms (META), Salesforce (CRM), NVIDIA (NVDA), Pfizer (PFE), Qualcomm (QCOM), AbbVie (ABBV) and Walt Disney (DIS). Company Calendar Last Earnings2/26/2026Today5/14/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Personal Services Sub-IndustryN/A Current SymbolLON:CVSG CIKN/A Webwww.cvsukltd.co.uk Phone+44-1379-644288FaxN/AEmployees9,100Year FoundedN/APrice Target and Rating Average Price Target for CVS GroupGBX 1,724 High Price TargetGBX 2,000 Low Price TargetGBX 1,420 Potential Upside/Downside+46.0%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)GBX 68.90 Trailing P/E Ratio17.14 Forward P/E Ratio12.57 P/E Growth1.77Net Income£20.68 million Net Margins2.31% Pretax MarginN/A Return on Equity5.35% Return on Assets5.03% Debt Debt-to-Equity Ratio121.52 Current Ratio1.07 Quick Ratio0.90 Sales & Book Value Annual Sales£692.80 million Price / Sales1.20 Cash FlowGBX 38.93 per share Price / Cash Flow30.33 Book ValueGBX 363.16 per share Price / Book3.25Miscellaneous Outstanding Shares70,157,000Free FloatN/AMarket Cap£828.55 million OptionableNot Optionable Beta1.02 The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (LON:CVSG) was last updated on 5/15/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVS Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share CVS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.